Výsledky vyhledávání - "Irene Viéitez"

Akademický článek

Plasma IGFBP-3 and IGFBP-5 levels are decreased during acute manic episodes in bipolar disorder patients

Autor: Carlos Fernández-Pereira, Maria Aránzazu Penedo, Adrián Alonso-Núñez, Tania Rivera-Baltanás, Irene Viéitez, José María Prieto-González, María Isabel Vilariño-Vilariño, José Manuel Olivares, Saida Ortolano, Roberto Carlos Agís-Balboa

Publikováno v: Frontiers in Pharmacology, Vol 15 (2024)

Introduction: Bipolar disorder (BD) is a recurrent and disabling psychiatric disorder related to low-grade peripheral inflammation and altered levels of the members of the insulin-like growth factor (IGF) family. The aim of this study was to evaluate

Externí odkaz: https://doaj.org/article/8ecb2509160e4af8bdbdc08d9f2d8570

Zobrazit plný text záznamu

Akademický článek

Systemic Treatment of Fabry Disease Using a Novel AAV9 Vector Expressing α-Galactosidase A

Autor: Maria Grazia Biferi, Mathilde Cohen-Tannoudji, Andrea García-Silva, Olga Souto-Rodríguez, Irene Viéitez-González, Beatriz San-Millán-Tejado, Andrea Fernández-Carrera, Tania Pérez-Márquez, Susana Teijeira-Bautista, Soraya Barrera, Vanesa Domínguez, Thibaut Marais, África González-Fernández, Martine Barkats, Saida Ortolano

Publikováno v: Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 1-17 (2021)

Fabry disease is a rare X-linked disorder affecting α-galactosidase A, a rate-limiting enzyme in lysosomal catabolism of glycosphingolipids. Current treatments present important limitations, such as low half-life and limited distribution, which gene

Externí odkaz: https://doaj.org/article/b2d13278a02c48deb45d598f9f6bd188

Zobrazit plný text záznamu

Akademický článek

SARS-CoV-2 Evolution and Spike-Specific CD4+ T-Cell Response in Persistent COVID-19 with Severe HIV Immune Suppression

Autor: Hortensia Álvarez, Ezequiel Ruiz-Mateos, Pedro Miguel Juiz-González, Joana Vitallé, Irene Viéitez, María del Carmen Vázquez-Friol, Isabel Torres-Beceiro, Alberto Pérez-Gómez, Pilar Gallego-García, Nuria Estévez-Gómez, Loretta De Chiara, Eva Poveda, David Posada, Josep M. Llibre

Publikováno v: Microorganisms, Vol 10, Iss 1, p 143 (2022)

Intra-host evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported in cases with persistent coronavirus disease 2019 (COVID-19). In this study, we describe a severely immunosuppressed individual with HIV-1/SARS-CoV

Externí odkaz: https://doaj.org/article/c25d134b4c77454eb84f78708944c8ec

Zobrazit plný text záznamu

Description of the first Spanish case of Gerstmann-Sträussler-Scheinker disease with A117V variant: clinical, histopathological and biochemical characterization

Autor: Hasier, Eraña, Beatriz, San Millán, Carlos M, Díaz-Domínguez, Jorge M, Charco, Rosa, Rodríguez, Irene, Viéitez, Arrate, Pereda, Rosa, Yañez, Mariví, Geijo, Carmen, Navarro, Guiomar, Perez de Nanclares, Susana, Teijeira, Joaquín, Castilla

Publikováno v: Journal of neurology. 269(8)

Gerstmann-Sträussler-Scheinker disease (GSS) is a rare neurodegenerative illness that belongs to the group of hereditary or familial Transmissible Spongiform Encephalopathies (TSE). Due to the presence of different pathogenic alterations in the prio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8c0a7a0bfdea06dbc099ae648f31ec29
https://pubmed.ncbi.nlm.nih.gov/35294616

Zobrazit plný text záznamu

Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study

Autor: Alexandre, Pérez-González, Alejandro, Araújo-Ameijeiras, Alberto, Fernández-Villar, Manuel, Crespo, Eva, Poveda, Irene, Viéitez

Publikováno v: Scientific reports. 12(1)

Survivors to COVID-19 have described long-term symptoms after acute disease. These signs constitute a heterogeneous group named long COVID or persistent COVID. The aim of this study is to describe persisting symptoms 6 months after COVID-19 diagnosis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::4cb094c126957acbca8468b73675dd5f
https://pubmed.ncbi.nlm.nih.gov/35974081

Zobrazit plný text záznamu

Systemic treatment of Fabry disease using a novel AAV9 vector expressing α-galactosidase A

Autor: Martine Barkats, Irene Viéitez-González, África González-Fernández, Mathilde Cohen-Tannoudji, Andrea Fernandez-Carrera, Beatriz San-Millán-Tejado, Maria Grazia Biferi, Vanesa Domínguez, Saida Ortolano, Susana Teijeira-Bautista, Olga Souto-Rodriguez, Tania Pérez-Márquez, Thibaut Marais, Soraya Barrera, Andrea Garcia-Silva

Publikováno v: Investigo. Repositorio Institucional de la Universidade de Vigo
Universidade de Vigo (UVigo)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development
Molecular Therapy-Methods and Clinical Development, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy-Methods and Clinical Development, Nature Publishing Group, 2021, 20, pp.1-17. ⟨10.1016/j.omtm.2020.10.016⟩
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 1-17 (2021)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2885db2614f355e811d45393c2dc42a5
https://linkinghub.elsevier.com/retrieve/pii/S2329050120302205

Zobrazit plný text záznamu

Akademický článek

Data from the European registry for patients with McArdle disease (EUROMAC): functional status and social participation

Publikováno v: Orphanet Journal of Rare Diseases, Vol 18, Iss 1, Pp 1-9 (2023)

Abstract Background The European registry for individuals with GSD5 and other muscle glycogenosis (EUROMAC) was launched to register rare muscle glycogenosis in Europe, to facilitate recruitment for research trials and to learn about the phenotypes a

Externí odkaz: https://doaj.org/article/36d94750141a4f249b7874ba6c6e46e8

Zobrazit plný text záznamu

Plný text ve formátu HTML

Vyhledávací nástroje:

Upřesnit hledání